These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16603792)

  • 1. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
    Bacman SR; Bradley WG; Moraes CT
    Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
    Pasinelli P; Brown RH
    Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas(t) balls and Lou Gehrig disease. A clue to selective vulnerability of motor neurons?
    Xiong ZQ; McNamara JO
    Neuron; 2002 Sep; 35(6):1011-3. PubMed ID: 12354390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
    Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
    PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death.
    Muyderman H; Hutson PG; Matusica D; Rogers ML; Rush RA
    Neurochem Res; 2009 Oct; 34(10):1847-56. PubMed ID: 19399611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
    Kawamata H; Manfredi G
    Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk5 sinks into ALS.
    Patzke H; Tsai LH
    Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of rapid disease progression in ALS.
    Yamanaka K; Cleveland DW
    Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
    Menzies FM; Cookson MR; Taylor RW; Turnbull DM; Chrzanowska-Lightowlers ZM; Dong L; Figlewicz DA; Shaw PJ
    Brain; 2002 Jul; 125(Pt 7):1522-33. PubMed ID: 12077002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
    Manfredi G; Xu Z
    Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
    Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
    Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent Models of Amyotrophic Lateral Sclerosis.
    Philips T; Rothstein JD
    Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.
    Jaarsma D; Rognoni F; van Duijn W; Verspaget HW; Haasdijk ED; Holstege JC
    Acta Neuropathol; 2001 Oct; 102(4):293-305. PubMed ID: 11603803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Shi P; Gal J; Kwinter DM; Liu X; Zhu H
    Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.